In the November issue of Drug Store News, we take a closer look at some of the leading women in retail pharmacy.
Decision Resources Group found that sales of biosimilar versions of the granulocyte colony-stimulating factors (G-CSFs) filgrastim and pegfilgrastim could reach $1.8 billion in the United States by 2023.
More specialty drug innovation, greater patient access to medicines and reduced impact from patent expiries will be the primary drivers of an increase in global medicine spending of up to 30% by 2018.
Emdeon announced it has entered into a definitive agreement to acquire Change Healthcare.
The Food and Drug Administration opened a public docket and requested comments on proposed criteria for “first generic” abbreviated new drug application submissions.
Nearly eight in 10 Americans (78%) would consider seeing a healthcare professional virtually for at least one healthcare need, according to a new Harris Poll.
Teva Canada Limited, a subsidiary of Teva Pharmaceutical Industries, on Tuesday announced that Health Canada has approved its application for PrTeva-Celecoxib, the generic equivalent of PrCelebrex.
Camber Pharmaceuticals on Monday announced their selection as a 2014 “Supplier of the Year” at Anda’s annual Supplier Strategy Meeting in Doral, Fla.
mHealth — the use of mobile technology devices and smartphones for healthcare purposes — is transforming health care as more Americans adopt mobile devices.
Last year, Drug Store News covered extensively the results from Thrifty White's successful medication synchronization program. DSN recently checked in with Tim Weippert, Thrifty White EVP pharmacy, to get an update.